ALBANY, N.Y., Dec. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 second quarter financial results on Thursday, January 5, 2012, after the close of the U.S. financial markets.
Joseph DeVivo, AngioDynamics' President and Chief Executive Officer, and Joseph Gersuk, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on January 5, 2012, to discuss the results and to answer questions.
To participate in the live call by telephone, please dial +1 (877) 941-6009.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' Web site at http://investors.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.
CONTACT: Company Contact: AngioDynamics, Inc. D. Joseph Gersuk, CFO (800) 772-6446 x1608 jgersuk@AngioDynamics.com Investor Relations Contacts: EVC Group, Inc. Greg Gin/Doug Sherk (646) 445-4801; (415) 652-9100 firstname.lastname@example.org; email@example.com Media Contact: EVC Group, Inc. Chris Gale (646) 201-5431 firstname.lastname@example.org